NCT01471847 2020-12-09A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to TrastuzumabNovartisPhase 1 Completed5 enrolled
NCT01495247 2020-12-08Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast CancerNovartisPhase 1/2 Terminated18 enrolled